Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

Nex Gen Health Rx Tirzepatide Review: $239 per 30-Day Supply (2026)

Nex Gen Health Rx charges $239 per 30-day supply of compounded tirzepatide, and every prepay rung is readable before the intake begins.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$130/mo below the $279 median
Market
$109–$429/mo across 388 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

Care Bare Rx

LegitScript-certified, with oral as well as injectable tirzepatide and a real brand Ozempic pathway — but per-dose pricing is quiz-gated.

From $199/mo*

Check Care Bare Rx availability

Nex Gen Health Rx sells compounded tirzepatide at $239 per 30-day supply, month to month at 2.5 mg weekly. That figure sits on the product page ahead of any account or questionnaire. The prepay rungs are one click away, and the longest of them was confirmed at the company's own checkout on 1 September 2026.1

What the ladder actually costs

Thirty days is $239 on the cadence you choose and prepaying costs $589 for 90 days, $1,074 for 180 and $1,788 for 360 — each charged in full at the start. Per-month equivalents of $196, $179 and $149 are printed beside those totals. The checkout prices the inclusions — doctor support at $99 and shipping at $40, both marked free — and it reached $1,788 with no medical question asked.

§ Nex Gen Health Rx — the tirzepatide ladder, read 1 September 2026

How you buyWhat is chargedPer-month equivalent
30 days, month to month$239 each cycle$239
90 days up front$589 once$196
180 days up front$1,074 once$179
360 days up front$1,788 once$149
The $149 the homepage advertises is the bottom rung of this ladder, and reaching it means handing over $1,788 before the first vial ships.

The "$99 a month" with no basis

The homepage advertises tirzepatide For as low as $149.00 a month and states no basis for it anywhere on that page. The basis lives on a separate landing page, in fine print saying prices are starting-at figures based on a 12-month plan paid in full. For semaglutide's matching $99.00 a month, that means $1,188 charged before anything ships. The landing page nonetheless sells the number as Every month, Fixed price and Price never increases, which is the vocabulary of a standing rate.

A named pharmacy, an unnamed company

Every page's footer names Manifest Pharmacy in Greer, South Carolina and gives that same address for returns, while the product pages state a class rather than a license number: 503A accredited pharmacies. The operator is harder to place because no legal entity is published anywhere, and no clinician, medical group or telehealth vendor is named either. The Terms then nominate Georgia law in one clause and California law in the arbitration clause, inside the same document.

The brand-vs-compounded question

What ships is compounded tirzepatide, disclosed on the product page as compounded and not FDA-approved. That means a pharmacy-made preparation rather than the finished product the agency reviewed, and our guide to whether compounded tirzepatide is still legal in 2026 covers where that stands.

How the care model holds up

A published ladder, a named pharmacy, a phone number and a Richmond address are genuine advantages, as is a checkout promising a refund if no prescription is written. The paperwork disagrees with itself repeatedly and refrigeration is the clearest case. The returns policy says refrigerated products are not shipped at all, the FAQ says they go out with cold packs, and a product page simply promises refrigerated shipping. Refunds split the same way, with the product FAQ offering unused months back while the returns policy makes all sales final once a carrier holds the package. The homepage also offers a pill to readers who dislike needles, yet the catalog's only oral weight-loss item is metformin, which is neither oral tirzepatide nor a GLP-1.

Does the drug work? (Separate from the provider)

Judge a seller on price, disclosure and oversight, and judge the molecule on its own trials. Tirzepatide's record is strong, at roughly 15% to 21% of body weight over 72 weeks in SURMOUNT-12, and ahead of semaglutide head to head in SURMOUNT-53. Both trials ran on the branded drug at approved doses, which is not what ships here.

The honest verdict

The $239 is honest, visible and confirmable at a checkout; the marketing wrapped around it is not. If you want pricing this open from a company willing to name itself, Nova quotes an all-in monthly figure and names a medical director, though that number is a floor rising with dose. If pharmacy disclosure drew you here, RENN Health names six pharmacies and two prescribers by NPI but attaches no billing cycle to its single price. The ranked best tirzepatide providers list places all three.

Frequently asked questions

How much does tirzepatide cost at Nex Gen Health Rx?

$239 per 30-day supply, month to month, at 2.5 mg weekly. Prepaying 360 days costs $1,788.

Is the homepage's $149 a month the real price?

Only as the per-month equivalent of that 360-day plan. It requires $1,788 paid up front.

Does Nex Gen Health Rx name its pharmacy and prescribers?

It names Manifest Pharmacy and states a 503A class. No clinician, medical group or legal entity is published.

References(3)

  1. Nex Gen Health Rx (2026). Compounded tirzepatide product pricing and supply tiers, checkout order summary, Terms of Use, Returns & Refund Policy and FAQ. nexgenhealthrx.com. https://nexgenhealthrx.com/
  2. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  3. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated September 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.